This federal contract award is a definitive contract between the Department of Health and Human Services' Food and Drug Administration (FDA) and Hartford Hospital, a non-profit hospital located in Hartford, Connecticut. The contract, valued at $249,975.00, is for research and development activities related to assessing the activity of the antibiotic cefepime against carbapenemase-producing Enterobacterales. This contract was awarded under the FDA's Broad Agency Announcement (BAA) for Advanced Regulatory Science, which sought proposals across various areas of regulatory science to support the FDA's mission. The contract does not have a set-aside designation. As the prime contractor, Hartford Hospital will provide research services, including patient screening, recruitment, data collection, and communication support. This contract is part of the FDA's ongoing efforts to modernize toxicology, support clinical innovation, and strengthen regulatory science.
Generated 3/23/24, 1:27 PM